Related Experiment Video
Updated: Mar 1, 2026

Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
Published on: October 1, 2019
Reduced regional cerebral blood flow in patients with heart failure
Bhaswati Roy1, Mary A Woo1, Danny J J Wang2
1School of Nursing, University of California Los Angeles (UCLA), Los Angeles, CA, USA.
Insights
Heart failure patients exhibit reduced cerebral blood flow (CBF), particularly in brain regions affecting autonomic, mood, and cognitive functions. This lateralized reduction in CBF likely contributes to neural injury and associated deficits in heart failure.
Area of Science:
- Neuroscience
- Cardiology
- Medical Imaging
Background:
- Heart failure (HF) is associated with neural injury, autonomic, mood, and cognitive deficits.
- These deficits may stem from altered cerebral blood flow (CBF) due to impaired cardiac output.
- The precise distribution of regional CBF changes in HF patients remains unclear.
Purpose of the Study:
- To compare regional CBF in HF patients versus control subjects.
- To investigate the distribution of CBF changes using pseudo-continuous arterial spin labelling (ASL).
Main Methods:
- Collected pseudo-continuous ASL data from 19 HF patients and 29 controls using 3.0-Tesla MRI.
- Calculated, normalized, and smoothed whole-brain CBF maps.
- Compared CBF between groups using ANCOVA, controlling for age, gender, and gray matter volume.
Main Results:
- HF patients demonstrated significantly reduced CBF compared to controls.
- The reduction in CBF was largely lateralized, affecting temporal, parietal, and occipital regions.
- Specific areas with decreased CBF included the cortex, thalamus, cerebellum, and hippocampus.
Conclusions:
- Heart failure patients exhibit reduced and lateralized CBF in key regulatory brain areas.
- This diminished CBF is a likely contributor to lateralized brain injury.
- The findings suggest a link between reduced CBF and the autonomic and neuropsychological deficits observed in HF.
Aims:
Heart failure (HF) patients show significant lateralized neural injury, accompanied by autonomic, mood and cognitive deficits. Both gray and white matter damage occurs and probably develops from altered cerebral blood flow (CBF), a consequence of impaired cardiac output. However, the distribution of regional CBF changes in HF patients is unknown, but is an issue in determining mechanisms of neural injury. Our aim was to compare regional CBF changes in HF with CBF in control subjects using non-invasive pseudo-continuous arterial spin labelling (ASL) procedures.
Methods And Results:
We collected pseudo-continuous ASL data from 19 HF patients [mean age 55.5 ± 9.1 years; mean body mass index 27.7 ± 5.3 kg/m2 ; 13 male) and 29 control subjects (mean age 51.4 ± 5.3 years; mean body mass index 25.7 ± 3.6 kg/m2 ; 18 male), using a 3.0-Tesla magnetic resonance imaging (MRI) scanner. Whole-brain CBF maps were calculated, normalized to a common space, smoothed and compared between groups using ANCOVA (covariates; age, gender and gray matter volume). Reduced CBF appeared in multiple sites in HF patients in comparison with controls, with principally lateralized lower flow in temporal, parietal and occipital regions. Areas with decreased CBF included the bilateral prefrontal, frontal, temporal and occipital cortex, thalamus, cerebellum, corona radiate, corpus callosum, hippocampus and amygdala.
Conclusions:
Heart failure patients showed lower, and largely lateralized, CBF in multiple autonomic, mood and cognitive regulatory sites. The reduced CBF is likely to contribute to the lateralized brain injury, leading to the autonomic and neuropsychological deficits found in the condition.
More Related Videos
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Heart Failure V: Medical Management
Heart Failure III: Clinical Manifestations
Pathophysiology of Heart Failure
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: β-Blockers

